Clinical outcome of patients with diabetes mellitus and chronic total occlusion treated with drug-eluting stents

Journal of Invasive Cardiology

Volumn 20, Issue 12, 2008, Pages 651-654

  De Felice, Francesco ^a   Fiorilli, Rosario ^a   Parma, Antonio ^a   Nazzaro, Marco Stefano ^a   Dibra, Alban ^a   Musto, Carmine ^a   De Santis, Antonella ^a   Violini, Roberto ^a  

^a SAN CAMILLO FORLANINI HOSPITAL   (Italy)

Author keywords

Chronic total occlusion; Diabetes; Drug eluting stent

Indexed keywords

CREATINE KINASE; FIBRINOGEN RECEPTOR ANTAGONIST; PACLITAXEL; RAPAMYCIN;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; BARE METAL STENT; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; DIABETES MELLITUS; DRUG ELUTING STENT; ELECTROCARDIOGRAM; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; PROTEIN BLOOD LEVEL; Q WAVE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CHRONIC DISEASE; CORONARY ARTERY DISEASE; DIABETIC ANGIOPATHIES; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LOGISTIC MODELS; MALE; METALS; MIDDLE AGED; PROGNOSIS; STENTS; TREATMENT OUTCOME;

EID: 57449115135     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Stone GW, Kandzari DE, Mehran R, et al. Percutaneous recanalization of chronically occluded coronary arteries: A consensus document: Part I. Circulation 2005;112:2364-2372.
2. Stone GW, Reifart NJ, Moussa I, et al. Percutaneous recanalization of chronically occluded coronary arteries: A consensus document: Part II. Circulation 2005;112:2530-2537.
3. Suero JA, Marso SP, Jones PG, et al. Procedural outcomes and long-term survival among patients undergoing percutaneous coronary intervention of a chronic total occlusion in native coronary arteries: A 20-year experience. J Am Coll Cardiol 2001;38:409-414.
4. Olivari Z, Rubartelli P, Piscione F, et al. Immediate results and one-year clinical outcome after percutaneous coronary interventions in chronic total occlusions: Data from a multicenter, prospective, observational study (TOAST-GISE). J Am Coll Cardiol 2003;41:1672-1678.
5. Ge L, Iakovou I, Cosgrave J, et al. Immediate and mid-term outcomes of sirolimus-eluting stent implantation for chronic total occlusions. Eur Heart J 2005;26:1056-1062.
6. Werner GS, Krack A, Schwarz G, et al. Prevention of lesion recurrence in chronic total coronary occlusions by paclitaxel-eluting stents. J Am Coll Cardiol 2004;44:2301-2306.
7. Suttorp MJ, Laarman GJ, Rahel BM, et al. Primary Stenting of Totally Occluded Native Coronary Arteries II (PRISON II): A randomized comparison of bare metal stent implantation with sirolimus-eluting stent implantation for the treatment of total coronary occlusions. Circulation 2006;114:921-928.
8. Migliorini A, Moschi G, Vergara R, et al. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion. Catheter Cardiovasc Interv 2006;67:344-348.
9. De Felice F, Fiorilli R, Parma A, et al. Clinical outcome of patients with chronic total occlusion treated with drug eluting stents. Int J Cardiol 2008, Jan 28; (in press).
10. Ledru F, Ducimetiere P, Battaglia S, et al. New diagnostic criteria for diabetes and coronary artery disease. Insights from an angiographic study. J Am Coll Cardiol 2001;37:1543-1550.
11. Prasad A, Rihal CS, Lennon RJ, et al. Trends in outcomes after percutaneous coronary intervention for chronic total occlusions: A 25-year experience from the Mayo Clinic. J Am Coll Cardiol 2007;49:1611-1618.
12. Dibra A, Kastrati A, Mehilli J, Pache J, Schühlen H, von Beckerath N, Ulm K, Wessely R, Dirschinger J, Schömig A; ISAR-DIABETES Study Investigators. Paclitaxel-eluting or sirolimus-eluting stents to prevent restenosis in diabetic patients. N Engl J Med 2005;353:663-670.
13. Sabate M, Jimenez-Quevedo P, Angiolillo DJ, et al. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: The diabetes and sirolimus-eluting stent (DIABETES) trial. Circulation 2005;112:2175-2183.
14. Moussa I, Leon MB, Baim DS, et al. Impact of sirolimus-eluting stents on outcome in diabetic patients: A SIRIUS (SIRolImUS-coated BX Velocity balloon-expandable sent in the treatment of patients with de novo coronary artery lesions) substudy. Circulation 2004;109:2273-2278.
15. De Felice F, Fiorilli R, Parma A, et al. Outcome of diabetic and non diabetic patients undergoing successful coronary angioplasty with bare stent of chronic total occlusion. J Cardiovasc Med 2006;7:847-851.
16. Rau T, Schofer J, Schutler M, et al. Stenting of non acute total coronary occlusions: